Zhu, Wandi <br/><br/>
Predicting Patient Response to the Antiarrhythmic Mexiletine Based on Genetic Variation.  [electronic resource] 

 -  Circulation research  02 2019 
 - 539-552 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4571 
<br/><br/><label>Standard No.: </label>10.1161/CIRCRESAHA.118.314050  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Animals<br/>Anti-Arrhythmia Agents--pharmacology<br/>Female<br/>HEK293 Cells<br/>Humans<br/>Ion Channel Gating<br/>Long QT Syndrome--drug therapy<br/>Male<br/>Mexiletine--pharmacology<br/>Mutation, Missense<br/>NAV1.5 Voltage-Gated Sodium Channel--chemistry<br/>Pharmacogenomic Variants<br/>Sodium Channel Blockers--pharmacology<br/>Xenopus